| A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study TRJF Scott JG, Berglund A, Schell MJ, Mihaylov I, Fulp WJ, Yue B, Welsh E ... Lancet Oncol 18 (2), 202-211, 2017 | 348 | 2017 |
| A gene expression model of intrinsic tumor radiosensitivity: prediction of response and prognosis after chemoradiation SA Eschrich, J Pramana, H Zhang, H Zhao, D Boulware, JH Lee, G Bloom, ... International Journal of Radiation Oncology* Biology* Physics 75 (2), 489-496, 2009 | 301 | 2009 |
| Systems biology modeling of the radiation sensitivity network: a biomarker discovery platform S Eschrich, H Zhang, H Zhao, D Boulware, JH Lee, G Bloom, ... International Journal of Radiation Oncology* Biology* Physics 75 (2), 497-505, 2009 | 246 | 2009 |
| Prediction of radiation sensitivity using a gene expression classifier JF Torres-Roca, S Eschrich, H Zhao, G Bloom, J Sung, S McCarthy, ... Cancer research 65 (16), 7169-7176, 2005 | 241 | 2005 |
| Melanoma, version 2.2016, NCCN clinical practice guidelines in oncology DG Coit, JA Thompson, A Algazi, R Andtbacka, CK Bichakjian, ... Journal of the National Comprehensive Cancer Network 14 (4), 450-473, 2016 | 229 | 2016 |
| Interleukin-1β converting enzyme–like protease involvement in Fas-induced and activation-induced peripheral blood T cell apoptosis in HIV infection. TNF-related apoptosis … PD Katsikis, ME Garcia-Ojeda, JF Torres-Roca, IM Tijoe, CA Smith, ... The Journal of experimental medicine 186 (8), 1365-1372, 1997 | 213 | 1997 |
| Validation of a Radiosensitivity Molecular Signature in Breast CancerA Radiosensitivity Molecular Signature in Breast Cancer SA Eschrich, WJ Fulp, Y Pawitan, JA Foekens, M Smid, JWM Martens, ... Clinical Cancer Research 18 (18), 5134-5143, 2012 | 198 | 2012 |
| The future of personalised radiotherapy for head and neck cancer JJ Caudell, JF Torres-Roca, RJ Gillies, H Enderling, S Kim, A Rishi, ... The Lancet Oncology 18 (5), e266-e273, 2017 | 152 | 2017 |
| Radiosensitivity differences between liver metastases based on primary histology suggest implications for clinical outcomes after stereotactic body radiation therapy KA Ahmed, JJ Caudell, G El-Haddad, AE Berglund, EA Welsh, B Yue, ... International Journal of Radiation Oncology* Biology* Physics 95 (5), 1399-1404, 2016 | 129 | 2016 |
| Integration of a radiosensitivity molecular signature into the assessment of local recurrence risk in breast cancer JF Torres-Roca, WJ Fulp, JJ Caudell, N Servant, MA Bollet, ... International Journal of Radiation Oncology* Biology* Physics 93 (3), 631-638, 2015 | 106 | 2015 |
| The radiosensitivity index predicts for overall survival in glioblastoma KA Ahmed, P Chinnaiyan, WJ Fulp, S Eschrich, JF Torres-Roca, ... Oncotarget 6 (33), 34414, 2015 | 106 | 2015 |
| NCCN guidelines insights: melanoma, version 3.2016 DG Coit, JA Thompson, A Algazi, R Andtbacka, CK Bichakjian, ... Journal of the National Comprehensive Cancer Network 14 (8), 945-958, 2016 | 99 | 2016 |
| A proliferation saturation index to predict radiation response and personalize radiotherapy fractionation S Prokopiou, EG Moros, J Poleszczuk, J Caudell, JF Torres-Roca, K Latifi, ... Radiation Oncology 10 (1), 1-8, 2015 | 95 | 2015 |
| Differences between colon cancer primaries and metastases using a molecular assay for tumor radiation sensitivity suggest implications for potential oligometastatic SBRT … KA Ahmed, WJ Fulp, AE Berglund, SE Hoffe, TJ Dilling, SA Eschrich, ... International Journal of Radiation Oncology* Biology* Physics 92 (4), 837-842, 2015 | 90 | 2015 |
| Radiosensitivity index predicts for survival with adjuvant radiation in resectable pancreatic cancer T Strom, SE Hoffe, W Fulp, J Frakes, D Coppola, GM Springett, MP Malafa, ... Radiotherapy and Oncology 117 (1), 159-164, 2015 | 79 | 2015 |
| Radiation therapy is associated with improved outcomes in Merkel cell carcinoma T Strom, M Carr, JS Zager, A Naghavi, FO Smith, CW Cruse, JL Messina, ... Annals of surgical oncology 23, 3572-3578, 2016 | 78 | 2016 |
| A molecular assay of tumor radiosensitivity: a roadmap towards biology-based personalized radiation therapy JF Torres-Roca Personalized medicine 9 (5), 547-557, 2012 | 78 | 2012 |
| The early intracellular production of a reactive oxygen intermediate mediates apoptosis in dexamethasone-treated thymocytes. JF Torres-Roca, H Lecoeur, C Amatore, ML Gougeon Cell death and differentiation 2 (4), 309-319, 1995 | 61 | 1995 |
| Radiosensitivity of lung metastases by primary histology and implications for stereotactic body radiation therapy using the genomically adjusted radiation dose KA Ahmed, JG Scott, JA Arrington, AO Naghavi, GD Grass, BA Perez, ... Journal of Thoracic Oncology 13 (8), 1121-1127, 2018 | 58 | 2018 |
| Pan-cancer prediction of radiotherapy benefit using genomic-adjusted radiation dose (GARD): a cohort-based pooled analysis JG Scott, G Sedor, P Ellsworth, JA Scarborough, KA Ahmed, DE Oliver, ... The Lancet Oncology 22 (9), 1221-1229, 2021 | 57 | 2021 |
Kamran AhmedDepartment of Radiation Oncology, H. Lee Moffitt Cancer Center & Research InstituteVerified email at moffitt.org
